Oesch, Franz

Adverse outcome pathways: opportunities, limitations and open questions

Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology

Animal testing and alternativesAgricultural safety and regulations

Cited by 394

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., Steinbach, D., Häfer, R., Stamminger, T., Oesch, F., Kaina, B., et al. (2004) · Free Radical Biology and Medicine

Sesquiterpenes and Asteraceae StudiesBioactive Compounds and Antitumor Agents

Cited by 266

Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver

Gebel, T., Arand, M., & Oesch, F. (1992) · FEBS Letters

Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism

Cited by 106

Cytotoxicity across OECD methods is not a single endpoint: context-dependent roles, variability and implications for decision-making

Thoma, T., Löhr, L., Demuth, P., Hambruch, N., Oesch, F., & Landsiedel, R. (2026) · NAM Journal

Animal testing and alternativesImmunotoxicology and immune responses

Cited by 0